Kaneka Eurogentec completes commercial mRNA GMP facility expansion
Newly accredited GMP facility for commercial manufacturing of mRNA in anticipation of customer BLA submission.
Exhibitions
More
TEMPLATE : Insert Title
[Insert Description]
[Article blog image should be : Minimum width: 800px and height: 600px]
[Article blog image should be : Minimum width: 800px and height: 600px]
17-21 September 2024
Campus Westend
Frankfurt, Germany
Eurogentec Showcasing at ESCV
17-21 September 2024
@ Frankfurt, Germany
Eurogentec will exhibiting during "ESCV", in Francfort, from September 17th to 21,2024. We look forward to meeting you there!
Company
More
Annual Closing 2024
Eurogentec will be closed from Wednesday the 25th of December 2024 until Wednesday the 1st of January 2025.
New Benchmark: 1 kg of Plasmid DNA Manufactured
Kaneka Eurogentec sets new benchmark in plasmid DNA manufacturing with the production of 1 kg of plasmid DNA
GMP Compliance Verification
PSC Biotech inspection results: AnaSpec, our American subsidiary, meets the requirements to produce Active Pharmaceutical Ingredients (Drug Substa...
Products & Services
More
VHH Antibodies: Current and emerging applications in therapy, diagnostics, and drug delivery
This article reviews current and emerging applications of VHH antibodies and discusses key trends shaping their future clinical translation.
The key role of plasmid DNA in therapeutic applications
Plasmid DNA has become an essential component of modern biopharmaceutical development. It provides a stable and adaptable way to introduce genetic ...
The hidden impact of residual DNA on microbial testing and how to avoid it
This article explores the hidden risks of residual bacterial DNA contamination in qPCR reagents and its impact on the integrity of microbial testin...